18 Mar 2026
Semaglutide Generic India Price 2026: The ₹3,000 Revolution
Semaglutide generics launch March 21 at ₹3,000-5,000/month — 50-70% cheaper than Ozempic. 50+ brands incoming, but price isn't the real barrier.
Markets, companies, startups, and economic policy affecting India.
Semaglutide generics launch March 21 at ₹3,000-5,000/month — 50-70% cheaper than Ozempic. 50+ brands incoming, but price isn't the real barrier.
Induction cooktop sales surge 300% as India's LPG crisis sparks panic buying. Amazon, Flipkart, Blinkit sold out. What the rush reveals about energy vulnerability.
Rupee hits record 92.45 vs dollar as oil crosses $101, FPIs pull ₹39,450 crore, and RBI burns $11.68 billion in reserves. What it means for you.
20% of Mumbai restaurants shut as LPG crisis deepens. Hormuz blockade chokes 85% of imports. What it means for your wallet.
Foreign portfolio investment in India declined ₹70,000 crore in Q1 2026. Discover why FIIs pulled out, how DIIs cushioned the impact, and what drives future flows.
India female workforce participation hit 35.1% in 2026. Tech hiring surges 31% while rural women remain in unpaid farm work. Female employment trends show stark gaps.
India GDP growth Q3 2026 hit 7.8%, but a base year shift and slowing agriculture tell a different story. The real test is the March heatwave hitting wheat fields.
India's auto sales in February 2026 surged with Hero MotoCorp up 44% and Tata Motors up 35%. New launches and GST tweaks are driving the growth.
India startups raised $3.3B across 332 deals in Q1 2026 — a 36% drop from Q1 2025. AI dominates, deal counts shrink, deep tech gets policy push.
RBI keeps repo rate at 5.25% in Feb 2026 MPC meeting. What the pause means for home loan EMIs, FD rates, and India's growth outlook.